鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/03/11 | 2,859 | 2,911 | 2,807 | 2,813 | -31 | -1.1% | 53,800 |
| 2020/03/10 | 2,688 | 2,849 | 2,678 | 2,844 | -15 | -0.5% | 68,700 |
| 2020/03/09 | 2,985 | 3,020 | 2,849 | 2,859 | -196 | -6.4% | 43,400 |
| 2020/03/06 | 3,070 | 3,135 | 3,045 | 3,055 | -75 | -2.4% | 52,000 |
| 2020/03/05 | 3,160 | 3,180 | 3,120 | 3,130 | +20 | +0.6% | 28,700 |
| 2020/03/04 | 3,085 | 3,135 | 3,060 | 3,110 | -35 | -1.1% | 58,700 |
| 2020/03/03 | 3,340 | 3,340 | 3,145 | 3,145 | -130 | -4% | 62,100 |
| 2020/03/02 | 3,155 | 3,305 | 3,145 | 3,275 | +50 | +1.6% | 51,500 |
| 2020/02/28 | 3,415 | 3,415 | 3,200 | 3,225 | -260 | -7.5% | 91,100 |
| 2020/02/27 | 3,455 | 3,505 | 3,445 | 3,485 | +40 | +1.2% | 70,900 |
| 2020/02/26 | 3,490 | 3,525 | 3,440 | 3,445 | -80 | -2.3% | 66,800 |
| 2020/02/25 | 3,515 | 3,595 | 3,490 | 3,525 | -100 | -2.8% | 59,500 |
| 2020/02/21 | 3,580 | 3,630 | 3,580 | 3,625 | +20 | +0.6% | 29,000 |
| 2020/02/20 | 3,645 | 3,645 | 3,580 | 3,605 | -10 | -0.3% | 31,400 |
| 2020/02/19 | 3,580 | 3,655 | 3,580 | 3,615 | +50 | +1.4% | 54,100 |
| 2020/02/18 | 3,595 | 3,600 | 3,535 | 3,565 | -25 | -0.7% | 42,200 |
| 2020/02/17 | 3,600 | 3,610 | 3,555 | 3,590 | -55 | -1.5% | 56,000 |
| 2020/02/14 | 3,630 | 3,680 | 3,595 | 3,645 | +40 | +1.1% | 64,200 |
| 2020/02/13 | 3,600 | 3,635 | 3,570 | 3,605 | +45 | +1.3% | 62,100 |
| 2020/02/12 | 3,600 | 3,625 | 3,560 | 3,560 | -65 | -1.8% | 76,500 |
| 2020/02/10 | 3,660 | 3,670 | 3,600 | 3,625 | -100 | -2.7% | 124,300 |
| 2020/02/07 | 3,740 | 3,805 | 3,670 | 3,725 | -85 | -2.2% | 181,600 |
| 2020/02/06 | 3,700 | 3,815 | 3,700 | 3,810 | +60 | +1.6% | 146,300 |
| 2020/02/05 | 3,765 | 3,785 | 3,695 | 3,750 | -15 | -0.4% | 71,500 |
| 2020/02/04 | 3,725 | 3,790 | 3,725 | 3,765 | +40 | +1.1% | 49,600 |
| 2020/02/03 | 3,700 | 3,760 | 3,660 | 3,725 | -10 | -0.3% | 68,200 |
| 2020/01/31 | 3,685 | 3,745 | 3,685 | 3,735 | ±0 | ±0% | 58,800 |
| 2020/01/30 | 3,800 | 3,835 | 3,730 | 3,735 | -90 | -2.4% | 67,300 |
| 2020/01/29 | 3,725 | 3,845 | 3,715 | 3,825 | +70 | +1.9% | 91,300 |
| 2020/01/28 | 3,715 | 3,795 | 3,715 | 3,755 | -20 | -0.5% | 63,800 |
| 2020/01/27 | 3,700 | 3,830 | 3,670 | 3,775 | +5 | +0.1% | 86,200 |
| 2020/01/24 | 3,770 | 3,820 | 3,710 | 3,770 | +45 | +1.2% | 97,700 |
| 2020/01/23 | 3,605 | 3,795 | 3,605 | 3,725 | +75 | +2.1% | 167,600 |
| 2020/01/22 | 3,600 | 3,650 | 3,560 | 3,650 | +80 | +2.2% | 113,800 |
| 2020/01/21 | 3,500 | 3,645 | 3,485 | 3,570 | +280 | +8.5% | 320,400 |
| 2020/01/20 | 3,255 | 3,315 | 3,250 | 3,290 | +20 | +0.6% | 44,800 |
| 2020/01/17 | 3,220 | 3,290 | 3,220 | 3,270 | +55 | +1.7% | 46,300 |
| 2020/01/16 | 3,185 | 3,215 | 3,135 | 3,215 | +30 | +0.9% | 33,500 |
| 2020/01/15 | 3,200 | 3,215 | 3,155 | 3,185 | -10 | -0.3% | 21,900 |
| 2020/01/14 | 3,260 | 3,275 | 3,170 | 3,195 | -90 | -2.7% | 48,900 |
| 2020/01/10 | 3,145 | 3,285 | 3,145 | 3,285 | +175 | +5.6% | 85,000 |
| 2020/01/09 | 3,070 | 3,110 | 3,060 | 3,110 | +85 | +2.8% | 29,100 |
| 2020/01/08 | 3,000 | 3,045 | 2,924 | 3,025 | ±0 | ±0% | 57,600 |
| 2020/01/07 | 3,010 | 3,035 | 2,994 | 3,025 | +15 | +0.5% | 19,700 |
| 2020/01/06 | 3,015 | 3,030 | 2,994 | 3,010 | -50 | -1.6% | 35,600 |
| 2019/12/30 | 3,045 | 3,075 | 3,020 | 3,060 | +10 | +0.3% | 25,700 |
| 2019/12/27 | 2,952 | 3,050 | 2,952 | 3,050 | +59 | +2% | 44,400 |
| 2019/12/26 | 2,973 | 2,991 | 2,956 | 2,991 | +10 | +0.3% | 16,000 |
| 2019/12/25 | 2,991 | 2,998 | 2,972 | 2,981 | -10 | -0.3% | 8,900 |
| 2019/12/24 | 3,030 | 3,035 | 2,982 | 2,991 | -5 | -0.2% | 17,200 |
1251～
1300
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 449,000円 | +7.1% | -35.0% | 2.67% | 37.12倍 | 1.03倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 381,500円 | +14.5% | -2.3% | 2.36% | 13.96倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 226,800円 | - | - | 0.00% | - | 105.05倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 253,800円 | +15.0% | -7.3% | 2.76% | 8.33倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.38倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
